Introduction
An estimated 17% of adults in the United States (US) have used a psychedelic drug, including psilocybin, Lysergic acid diethylamide (LSD), 3,4-Methylenedioxymethamphetamine (MDMA), or another serotonin agonists, at least once in their lifetime, (Krebs and Johansen Reference Krebs and Johansen2013) with recent data showing steadily increasing prevalence and frequency (Killion et al. Reference Killion, Hai and Alsolami2021). The potential of psychedelic drugs to address the symptoms of numerous difficult-to-treat mental health issues has garnered substantial scientific interest over the past decade. Broad areas of scientific interest in psychedelic-related outcomes include anxiety, depression, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and addiction (Andersen et al. Reference Andersen, Carhart‐Harris and Nutt2021; Griffiths and Grob Reference Griffiths and Grob2010; Muttoni et al. Reference Muttoni, Ardissino and John2019).
Patients with serious illness in the palliative care context have proved an especially important population for psychedelic-assisted therapy interventions given their high symptom burden and risk for a compromised quality of life, often compounded by decreased functional independence, autonomy, and agency (Bhagavan et al. Reference Bhagavan, Glue and Evans2024; Wang et al. Reference Wang, Mendez Araque and Micciche2024). In an online population-based survey of psilocybin-assisted therapy’s social acceptability for existential distress at the end-of-life among 2800 adult respondents across 4 Canadian provinces, 79.3% of respondents considered psilocybin assisted therapy a reasonable medical choice, 84.8% agreed that costs should be covered by the public health system, and 63.3% would welcome its legalization for medical purposes (Plourde et al. Reference Plourde, Chang and Farzin2024). Common symptoms in the palliative care population may include spiritual and existential distress, anxiety, depression, demoralization, and hopelessness, in addition to a sense of isolation, disconnection, and loss of meaning – complex symptoms and experiences that psychedelic-assisted therapy has been shown to address.
Empirical psychedelic research to date has largely focused on individual treatment in clinical trials, delivering the intervention to a single “client” with therapeutic and research teams guiding the process. This dominant individualist structure exists in stark contrast to collectivist healing modalities of various indigenous psychedelic traditions (e.g., ayahuasca ceremonies, peyote churches) that have historically recognized the power of community as a healing force (George et al. Reference George, Michaels and Sevelius2020; Metzner Reference Metzner2015). Within the broader realm of society, there is a growing body of literature showing the negative physical and mental health implications of social isolation – particularly following the COVID-19 pandemic, as well as increased emphasis on the role of community in promoting increased psychosocial support and well-being across the life course (Alsarrani et al. Reference Alsarrani, Hunter and Dunne2022; D’Eer et al. Reference D’Eer, Quintiens and Van den Block2022; Naito et al. Reference Naito, McKee and Leong2023; Liebermann et al., Alsarrani et al. Reference Alsarrani, Hunter and Dunne2022; Prommas et al. Reference Prommas, Lwin and Chen2022; Sallnow et al. Reference Sallnow, Smith and Ahmedzai2022). Thus, community connection and group therapy practices that support it may be particularly important to healing for those with serious illness in the post-pandemic era.
Data emphasizing the importance of community connection in psychedelic experiences is growing (Dames et al. Reference Dames, Kryskow and Watler2022; Forstmann et al. Reference Forstmann, Yudkin and Prosser2020; Kettner et al. Reference Kettner, Rosas and Timmermann2021; Watts et al. Reference Watts, Kettner and Geerts2022). For instance, researchers have reported significant improvements in depression, anxiety, PTSD, and work/life functionality using a community of practice model in a ketamine-assisted intervention for multidisciplinary health workers (Dames et al. Reference Dames, Kryskow and Watler2022). MDMA- and LSD-group therapy over time has suggested group-level development (e.g., mutual support outside of therapy, friendships, conflict, and alterations in individuals’ relationships to others in a population with trauma-related disorders (Oehen and Gasser Reference Oehen and Gasser2022). Group therapy approaches to psilocybin-assisted therapy in patients with advanced cancer have been shown to be feasible and acceptable to participants (Beaussant et al. Reference Beaussant, Tarbi and Nigam2024). Furthermore, group psilocybin-assisted therapy approaches for patients with cancer and major depressive disorder have also demonstrated safety, feasibility, and efficacy based on clinically meaningful reductions in depressive symptoms (Agrawal et al. Reference Agrawal, Richards and Beaussant2024). Ayahuasca’s ritual spaces, which emphasize collective consumption, ethics of care, and interpersonal caregiving, are considered fundamental to its efficacy in the treatment of substance addiction (Cosimano Reference Cosimano, Grob and Grigsby2021; Dupuis Reference Dupuis2022; Fairlamb Reference Fairlamb2016; Goldberg and Hoyt Reference Goldberg and Hoyt2015; Joshi Reference Joshi2022; Phelps Reference Phelps2017; Phelps and Henry Reference Phelps and Henry2021; Talin and Sanabria Reference Talin and Sanabria2017).
Outcomes and experiences associated with the naturalistic use of psychedelics (i.e., nonclinical setting use), often communal and relational in nature, have been both undervalued and understudied in the field (Dorsen et al. Reference Dorsen, Palamar and Shedlin2019). However, limited available research suggests that increased social connectedness and self-reported transformative experiences mediate the elevated positive mood associated with psychedelics. Moving forward, the influence of group work before, during and after psychedelic experiences will be the subject of much interest as the scientific community considers how to promote equity, access, and scalability of psychedelic-assisted psychotherapy once Food and Drug Administration (FDA)-approved (National Academies of Sciences, Engineering, and Medicine 2022).
To this end, we conducted a secondary analysis of existing qualitative data to explore the perception of the role of community in “underground” psychedelic groups (Dorsen et al. Reference Dorsen, Palamar and Shedlin2019) in the US. Core therapeutic forces of effective group therapy, based on the formative work done by Yalom and Crouch (Reference Yalom and Crouch1990), were applied to guide data analysis, as described in methods below (see Table 1). Findings describe the role of community and relational health in the context of psychedelics while filling a substantial literature gap. For this study, we use the term “group” to reflect a collection of people who come together to use psychedelics with the stated intention of healing. In some cases, this is once, but in many cases, it is repeatedly over months, years or even decades. We use the term “community” to reflect the interpersonal relationships formed in these groups and the larger group of psychedelic users nationally and internationally.
Table 1. Yalom therapeutic forces in group therapy (Yalom and Leszcz Reference Yalom and Leszcz2020)
Methods
The aim of this secondary qualitative analysis was to explore how facilitators of naturalistic psychedelic groups in the US described the role of community in psychedelic health and healing. This study utilized a modified ethnographic methodology incorporating in-depth, semi-structured interviews with individuals facilitating psychedelic ceremonies in diverse geographic regions of the US. In lieu of traditional participant observational ethnographic methods, the modified ethnographic approach in this study conducted interviews over the phone in order to ensure participant anonymity and facilitate study participation (Dorsen et al. Reference Dorsen, Palamar and Shedlin2019; Rashid et al. Reference Rashid, Caine and Goez2015). In keeping with ethnographic methods, the study did not incorporate a theoretical framework a priori (Rashid et al. Reference Rashid, Caine and Goez2015). However, the well-researched and clinically utilized core therapeutic forces of effective group therapy (Yalom and Crouch Reference Yalom and Crouch1990; Yalom and Leszcz Reference Yalom and Leszcz2020) were used to structure data analysis (See Table 1) and frame the findings in the context of existing literature.
The parent study was approved by New York University Institutional Review Board (IRB) and included a sample of 15 participants who were recruited via key informants and snowball sampling. Inclusion criteria included the following: 18 years of age or older, English speaking, and currently facilitating naturalistic psychedelic group ceremonies within the US. Participants with knowledge of the psychedelic community, culture, protocol, and controversies were selected. As part of a larger study on the growing phenomenon of psychedelic use in the US, the study principal investigator developed an interview guide which addressed topics such as how individuals perceived the purpose and philosophy behind psychedelic ceremonies, the perceived benefits of therapeutic psychedelic use, the perceived risks and limitations of use, similarities and differences between psychedelic-assisted psychotherapy and other modalities of treatment (including individual and group talk therapy), and the differences between recreational and ceremonial drug use (Dorsen et al. Reference Dorsen, Palamar and Shedlin2019).
Interviews were conducted between January and June of 2016 and lasted between 60 and 120 minutes. Following the approved IRB protocols, interviews were recorded and transcribed by a professional transcriptionist. Participants of this study gave verbal informed consent to protect anonymity and demographic data was collected categorically (for example, decade of life rather than age in years). Audio recordings and transcripts were housed on a password-secured computer in a locked office without any identifying information.
Data saturation was met after 15 formal interviews. Directed content analysis was facilitated by use of Dedoose © online qualitative data program to sort and manage qualitative data. Content analysis of the interviews included multiple readings of the transcripts and lengthy discussion among the research team members to illuminate recurring patterns and themes related to community. To this end, transcripts were coded in a multistep process. First, a list of keywords was identified by the research team and transcripts were coded by terms such as community, group, relational, support, and friend/friendship. Next, codes were grouped into categories developed both inductively from the data and deductively from the 11 therapeutic forces in effective group therapy developed by Irvin Yalom, a pioneer of group therapy (See Table 1) (Yalom and Crouch Reference Yalom and Crouch1990). Finally, categories were condensed and organized into 2 thematic topics with multiple subthemes. Throughout the analysis process 25% of transcripts were coded by 2 researchers to establish inter-coder reliability and ensure qualitative rigor (Squires and Dorsen Reference Squires and Dorsen2018). To further ensure rigor, direct exemplar quotations from participant’s interviews are highlighted throughout this paper to present participant’s opinions and experiences in their own words. Occasionally quotations have been edited to remove verbal pauses without altering the quotation’s meaning or context.
Results
Study participants
The sample in this study consisted of 15 psychedelic group facilitators who collectively have worked with thousands of participants using various psychedelics, including ayahuasca, psilocybin, San Pedro and MDMA. The sample was 80% white (n = 12) and 66.6% female (n = 10) with 100% of participants having a Bachelor’s degree or higher. Participants had diverse religious backgrounds and professional identities, lived throughout the US and had been leading psychedelic groups for a minimum of 3, and a maximum of 30, years. Of importance, many participants in this study both lead psychedelic sessions and have participated in psychedelic sessions themselves. Thus, their stories sometimes related to others’ experiences and sometimes to their own.
Qualitative findings are categorized into themes and subthemes as follows – Theme 1: The arc of healing through community (Subthemes: Community as intention, the group psychedelic journey experience, Community and integration); Theme 2: Naturally occurring psychedelic communities as group therapy (Subthemes [as described in Table 2]: Belonging, authenticity, corrective experience, trust, touch).
Table 2. Subthemes, exemplar quotes, and corresponding group talk therapy concepts
Theme 1: The arc of healing through community
The role and importance of community was reflected in all aspects of participants’ stories in this study and mirrored the arc of the journeyFootnote 1 experience from intention setting to psychedelic participation to ongoing integration after their psychedelic experience. Numerous participants in this study considered community to be one of the main efficacy pathways of psychedelics. As one participant stated
For me, [psychedelics are] about remembering and re-experiencing safe connections with other humans … There is so much disconnection in the world … so when I meet new people and I’m describing just the beginning of what this offers, I personally emphasize that the healing, the unique healing that comes from doing this work, is community.
Another participant echoed this perspective, reflecting that the individual and societal need for psychedelic work comes from lack of connection, and the potential power of psychedelics lies in their ability to help heal a disconnected world:
I think that [community] is something we’re missing as a modern society, and we need that again. We’re so driven away from our families and … where we came from … we need to feel connected again. And I feel like [psychedelics are] a tool that could help with that.
Community as intention
Intention setting is a key aspect in the therapeutic use of psychedelics (Dorsen et al. Reference Dorsen, Palamar and Shedlin2019) and refers to participants’ motivations for participation in therapeutic psychedelic journeys. Intentions may be narrowly focused on what a participant hopes to get out of a specific psychedelic experience and/or address the bigger picture of what a participant is seeking to clarify or change in their lives. Intention setting may lend a structure to what is experienced in psychedelic journeys and/or help frame a narrative for interpretation of the experience in the days, weeks, or even years afterward (Frecska et al. Reference Frecska, Bokor and Winkelman2016). In this study, participants often stated that community figured into their own motivation for working with psychedelics and/or was a common intention for those they were guiding in psychedelic groups. One participant described this by saying that they personally chose to take psychedelics because they “were looking for a place of tribe.” Another study participant explained that they had been “looking for [community] for all [their] life” and that they found it in a psychedelic community.
The group psychedelic journey experience
Participants in this study also spoke about the role of community and connection during the psychedelic experience itself. Some study participants described the “safe space” of psychedelic communities as a driver of positive experiences during journeys. One described a journey as “supportive and nurturing … relational space[s]” where there is “reciprocity and mutual respect.” Another participant explained that during a journey “you experience this feeling of belonging, you feel connection, you feel enchanted with everybody that’s there” and that this experience creates an opportunity for relearning how to trust and connect on a deeper, more meaningful level. However, others spoke about connection and community in journey space as being most powerful during difficult experiences that commonly occur when taking psychedelics, such as reliving trauma or experiencing fear. In one example, a facilitator spoke about how community helps participants make meaning of these difficult experiences, thereby allowing them to reframe the experience as important and powerful (as opposed to harmful or traumatizing). They stated the following:
[You may fall apart during a journey] but you fall apart in community, you’ve got people holding you, you’ve got people asking you questions … allowing [trauma] to flow so that it can move through you and out the other side, and you can come out shiny and clean from the experience.
Another study participant described being there for others during difficult experiences as part of the way that psychedelics may also change painful narratives for those who serve in the role of supporter:
it’s really about being a compassionate witness, I am here to support you in anything you want to say or do, and being love and safety for them.
Community and integration
Finally, participants in this study described the role that community plays in psychedelic integration. Integration is an essential part of the therapeutic use of psychedelics and refers to the ongoing “process in which the patient integrates the insights of their experience into their life” (Gorman et al. Reference Gorman, Nielson and Molinar2021). In this study, participants commonly reflected on the healing experience of being in a supportive community as one of the lasting benefits of working with psychedelics. One participant described participating in a psychedelic circle as a
corrective experience that … creates a template that I can take into my own life.
Another stated
the healing comes specifically through the community portal, through recreating a sense of tribe and connection between people that you can trust and that you know is going to continue. And that to me is one of the unique things that this community offers.
Theme 2: Naturally occurring psychedelic communities as group therapy
Along with describing the role of community occurring throughout the arc of the psychedelic experience, participants in this study spoke about the specific multidimensional ways that group psychedelic experiences aided in their healing process. The majority of these categories corresponded directly to therapeutic concepts well known in traditional talk-based group therapy and included belonging, authenticity, corrective experience, and trust (see Table 2).
One participant described psychedelic groups as “a cosmology of belonging” illustrating the multifaceted ways that therapeutic groups function to ensure that all feel welcome, seen, heard, and respected while also allowing for at-times supportive and at other times corrective individual interpersonal learning. Some participants in this study, who themselves work as traditional psychotherapists when not guiding psychedelic ceremonies, commented on the similarities and differences between psychedelic group work and traditional therapeutic work. When describing why they felt psychedelics offered something different than traditional talk therapy, one participant stated
the huge component in this work has been around community. And as a psychotherapist, I felt like wow, there really are limitations around all of the boundaries and the lack of community [in traditional talk therapy]. And I understand that those things are in place for good reason – I implement them with my clients on a daily basis. However, because my trauma happened in the context of relationship, there’s certain things that I feel come up in the context of the community where I can get feedback and I can draw on the resources of community in a way that I’ve never really been able to [in talk therapy].
However, in contrast to most traditional group talk-based therapeutic processes that do not involve the use of touch, some participants in this study spoke about the role of nonsexual touch in psychedelic group work. One participant described the intentional use of touch to create a physical sense of safety to optimize the therapeutic process, stating
I work with people and hold them in love and safety so that they can go within themselves and do what it is they need to do.
Another described the role of touch within the group as
equally important as any kind of intellectual understanding we have. The physicality and the desire for our mammalian bodies to be up against each other’s bodies, is so outstanding in the journey space, it’s like how come in my everyday life, I can’t, I don’t access that?
Discussion
This secondary qualitative data study was built on a larger modified ethnographic study of psychedelic use in the US. The original study concluded that participants in that small, qualitative study saw psychedelic use as “a self-care and healing modality that is used in the context of community and ritual” (Dorsen et al. Reference Dorsen, Palamar and Shedlin2019). The present study sought to explore how participants discussed the role of community in this context, considering: (1) that social isolation and lack of connection are major drivers of the current mental health crisis in the US and globally, (2) that the majority of promising clinical trials on psychedelics for these mental health problems have been individually focused, and (3) that group work may be an important aspect of psychedelic-assisted psychotherapy as we work to ensure equitable access to these treatments should they be FDA-approved. These themes are particularly important for people with serious illness in the palliative care context where equitable access to mental and existential health interventions, such as psychedelic-assisted therapy, are lacking.
Participants in this study saw community as an essential aspect of every aspect of naturalistic psychedelic work, from the motivation to use psychedelics, to the psychedelic dosing experience itself, to the integration of lessons learned during psychedelic experiences into everyday life. Much of this has not previously been fully described in the literature. A 2019 historical review (Trope et al. Reference Trope, Anderson and Hooker2019) found that group settings were commonly used in the early days of Western psychedelic research, and may have improved participant satisfaction, patient outcomes and cost effectiveness but identified major gaps in the literature. A more recent web-based quantitative study by Kettner et al. (Reference Kettner, Rosas and Timmermann2021) used an adaptation of the Communitas Scale to examine the correlation between a sense of “togetherness and shared humanity” during ceremonies and long-term mental health outcomes, finding that community connection during psychedelic ceremonies was positively correlated with participant well-being after ceremonies.
There is a larger body of literature describing the role of community, both generally and in the context of psychedelics, in the indigenous communities who have been using these substances for millennia in rituals, ceremonies, and rites of passage (Stein et al. Reference Stein, Penn and Van Hope2022). Among many indigenous communities “… human lives are interdependent with and contingent on living in ethical relations with other people, with our ancestors, with plants and animals, and with the natural world overall. Indigenous systems of relationality are the heartbeat of Indigenous existence. They help to illuminate approaches to physical, intellectual, emotional, and spiritual health” (Elliott-Groves et al. Reference Elliott-Groves, Hardison-Stevens and Ullrich2020). Recognizing and honoring indigenous ways of knowing may help frame the structure and experience of clinical psychedelic work, while reminding participants, healthcare workers and researchers of the need for humility and grace in this work.
Participants in this study also articulated their belief that community is an important mechanism for how psychedelics work to promote health and healing via decreased isolation and increased reciprocal and authentic connection, trust and care. This is an important finding as clinical trials have almost exclusively been individually based and hypotheses regarding pathways of efficacy of psychedelics have primarily focused on the spiritual (mystical experiences) (Johnson et al. Reference Johnson, Hendricks and Barrett2019) structural neurobiological (neural plasticity) (Calder and Hasler Reference Calder and Hasler2023) and biochemical (serotoninergic) (Carhart‐Harris Reference Carhart‐Harris2018) rather than the relational. The findings of this study suggest that relational health may be an important pathway to explore moving forward and that administering psychedelics in community may not be a “good but lesser” option (as compared to individual work), but rather may offer benefits that individual work does not and/or be more efficacious than individually situated care (Kettner et al. Reference Kettner, Rosas and Timmermann2021; Liebmann et al., Reference Liebmann, Pitman and Hsueh2022). More research is needed on how to optimize group use of psychedelics, including size and composition of groups, selection and dosing of psychedelic substances in a group context, training of facilitators and ongoing integration (National Academies of Sciences, Engineering, and Medicine 2022). Of note, studies among patients with serious illness are particularly important to not only meet a pressing need for symptom and distress management, but also optimize intervention delivery that decreases system, therapist, and administrative burden while providing pragmatic and convenient opportunities for therapeutic (Agrawal et al. Reference Agrawal, Richards and Beaussant2024; Beaussant et al. Reference Beaussant, Tarbi and Nigam2024).
Community as medicine in other aspects of health and healing, such as in 12 step and other groups formed to support people with substance use disorder, has been well described in extant literature (Kelly et al. Reference Kelly, Humphreys and Ferri2020). For example, group talk therapy has long been a leading treatment modality for mental health concerns including: major depressive disorder, bipolar disorder, panic disorder, PTSD, social phobia, OCD, bulimia nervosa, binge-eating disorder, substance use disorder, schizophrenia, borderline personality disorder, and general personality disorders (Lucre and Corten Reference Lucre and Corten2013) (Brennan et al. Reference Brennan, Emmerling and Whelton2014) (Feng et al. Reference Feng, Chu and Chen2012) (Wolgensinger Reference Wolgensinger2022). Group therapy explores an individual’s social tendencies and allows for healing within a supportive, socially connected context (Whittingham Reference Whittingham2018). Among populations with serious illness, approaches such as meaning-centered group psychotherapy (MCGP) have shown increased sense of meaning and spiritual well-being, as well as decreased anxiety, depression, hopelessness, physical symptom distress, and desire for hastened death (Breitbart et al. Reference Breitbart, Rosenfeld and Pessin2015). Although researchers have found that some short-term effects of MCGP on participants faded with time (e.g., personal meaning, some effects related to psychological well-being), the long-term positive effect on positive relations with others was sustained (Holtmaat et al. Reference Holtmaat, van der Spek and Lissenberg‐Witte2020). Thus, as psychedelic-assisted therapy interventions are increasingly implemented in palliative and supportive care contexts, it is essential to assess the feasibility and appropriateness of group therapy settings, and combined efficacious interventions such as MCGP in addition to psychedelic-assisted therapy, to enhance the possibility of lasting benefit and a sense of connection with others, which may bolster personal growth and coping resources.
Findings in this study suggest that existing knowledge about therapeutic group processes used in these other contexts may be helpful in structuring and optimizing group psychedelic work moving forward (Agrawal et al. Reference Agrawal, Richards and Beaussant2024; Beaussant et al. Reference Beaussant, Tarbi and Nigam2024; Wang et al. Reference Wang, Mendez Araque and Micciche2024). Central themes in this study, including belonging, authenticity, corrective experience and trust, correspond to well-documented concepts of effective therapeutic group therapy (Yalom and Crouch Reference Yalom and Crouch1990) (Agrawal et al. Reference Agrawal, Richards and Beaussant2024; Beaussant et al. Reference Beaussant, Tarbi and Nigam2024; Wang et al. Reference Wang, Mendez Araque and Micciche2024). These include universality, group cohesiveness, instillation of hope, interpersonal learning, corrective emotional experiences, and development of socialization techniques (See Table 2) (Yalom and Crouch Reference Yalom and Crouch1990). Implications for palliative care and psychedelic-assisted therapy research can be found in Table 3.
Table 3. Implications for future palliative care and psychedelic-assisted therapy research
However, as researchers and clinicians consider the potential benefits of group work in the context of psychedelics and palliative care, it is essential to also that they also consider the potential pitfalls and negative outcomes of group work previously described in the literature. These include decreased confidentiality, decreased accountability, less flexibility, decreased therapeutic alliance, less focused individual attention, a poor fit between a participant and therapist or other group members, and the ability for individuals to “hide” in groups (Yalom and Leszcz Reference Yalom and Leszcz2020). Future qualitative and quantitative research should measure both positive and negative outcomes of group work and consider interventions to optimize the therapeutic potential of groups while minimizing potential pitfalls.
Limitations
Limitations related to design, analysis, and sample are essential to consider. First, the study was a secondary analysis of existing data, (Dorsen et al. Reference Dorsen, Palamar and Shedlin2019) preventing follow-up or clarification of content with interview participants. For example, we could not ask more detailed questions about psychedelic participation, such as how often participants attended groups and/or if they had also participated in individual sessions. As well, the potential harms or risks associated with group work in this context were not explored in the parent study but will be important to explore moving forward. In this study, consistent data was identified, allowing for therapeutic saturation within 15 interviews. However, the snowball sampling method used in the original study could have resulted in sampling bias, leading to premature data saturation. The results of this small qualitative study are not meant to be generalizable but rather offer a window into a complex phenomenon and community. Next, we used the core components of the group therapy dynamics to guide data analysis, which ensured that findings from this study could be considered in the context of what is already known about group therapy generally. However, this decision may have prevented a more inductive interpretation of available thematic content. While this analytic approach may have potentially led to the exclusion of important experiences, the findings contribute to filling the notable gap related to well-established group therapy forces and the role of community in psychedelic-assisted therapy. Finally, participants predominantly identified as white and consisted of psychedelic group facilitators, limiting diversity in perspective and cross-cultural insight.
Conclusion
Through shared values and experience, and the changing relationships to self, other, nature, and spirit often seen in psychedelic use, psychedelic communities may optimize the healing power of psychedelics while also offering a structure to improve access for all. Future research should focus on how to minimize any potential harms and best optimize community experiences for the benefit of individuals, families, and society at large, particular among those with serious illness. Community connection in the psychedelic-assisted therapy milieu can become yet another therapeutic tool to garner social support, empathy, and understanding while alleviating the sense of isolation and despair that often accompanies the serious illness experience.
Acknowledgments
The authors would like to thank The Center for Drug Use and HIV Research (CDUHR) and Meyers College of Nursing at NYU for their generous grant support and Drs. Joseph Palamar, PhD, MPH and Michele Shedlin, PhD for academic mentorship and assistance with the original study from which this project was born. WER is partially funded by the NIH/NCI comprehensive cancer center award P30CA008748.
Competing interests
Caroline Dorsen: none; Lola Noero: none; Michelle Knapp: none; Kristin Arden: Is clinical lead at Mindbloom, a for-profit ketamine provider; William Rosa: none.
Open access
